Kaly Queiroz ’24 MBA reflects on how the Executive MBA Program has sharpened her leadership skills, enabling her to navigate ...

Incyte (INCY) shares are sinking after its third phase results for Povorcitinib, a drug for chronic skin disease, were less promising than those from earlier trials. Yahoo Finance Senior Reporter ...